Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Palmar erythema, Peripheral swelling, Pruritus, Rheumatoid arthritis, Rheumatoid factor quantitative
Clinical narrative: erythematous palms; anxiety; hands swelling; Itchiness; joint pain; muscle aches; Rheumatoid Arthritis; slight elevation of Scleroderma; This spontaneous case was reported by an other health care professional and describes the occurrence of RHEUMATOID ARTHRITIS (Rheumatoid Arthritis) and SCLERODERMA (slight elevation of Scleroderma) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concurrent medical conditions included Seasonal allergy since 19-May-2021. Concomitant products included AMLODIPINE for an unknown indication.   On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Mar-2021, the patient experienced SCLERODERMA (slight elevation of Scleroderma) (seriousness criterion medically significant). On an unknown date, the patient experienced RHEUMATOID ARTHRITIS (Rheumatoid Arthritis) (seriousness criterion medically significant), PALMAR ERYTHEMA (erythematous palms), ANXIETY (anxiety), PERIPHERAL SWELLING (hands swelling), PRURITUS (Itchiness), ARTHRALGIA (joint pain) and MYALGIA (muscle aches). The patient was treated with PREDNISONE at a dose of 20mg; BUSPIRONE HYDROCHLORIDE (BUSPAR) at a dose of 15mg bid; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and OMEPRAZOLE at a dose of 5mg OD. At the time of the report, RHEUMATOID ARTHRITIS (Rheumatoid Arthritis), SCLERODERMA (slight elevation of Scleroderma), PALMAR ERYTHEMA (erythematous palms), ANXIETY (anxiety), PERIPHERAL SWELLING (hands swelling) and MYALGIA (muscle aches) outcome was unknown and PRURITUS (Itchiness) and ARTHRALGIA (joint pain) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-May-2021, Blood immunoglobulin E: increased (abnormal) Consultation with the Allergist on 19th Mar 2021 recorded high Ig E of 161 and mentioned as seasonal Allergies. On 24-May-2021, Antinuclear antibody: positive ana (Positive) Positive. On 24-May-2021, Rheumatoid factor quantitative: low (Low) low titer level, slight elevation of Scleroderma.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.  The past history of Rheumatoid arthritis is a confounder..   This case was linked to MOD-2021-116524 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.  The past history of Rheumatoid arthritis is a confounder.